Industry Educational Session - Showcasing clinical innovation across the CAR-T pathway: hear about completed and ongoing clinical projects aiming to improve patient care - Sponsored by Gilead
Tracks
Track 5
| Monday, April 29, 2024 |
| 4:30 PM - 5:15 PM |
| Room 4 |
Details
Presentation titles:
- Establishment of a comprehensive pre-habilition programme for ASCT and CAR-T patients
- Implementation of a late effects clinic for CAR-T patients
- Profiling the cancer microbiome to predict CAR-T outcomes
This symposium is organised and fully funded by Gilead Sciences Ltd. CAR-T products including those from Gilead will be discussed in this symposium. The projects showcased within this symposium have received grant funding from Gilead. Gilead has had no involvement in the creation, design or conduct of these projects.
ASCT, autologous stem cell transplant; BMT, bone marrow transplant; CAR-T/CAR T-cell, chimeric antigen receptor T-cell.
Speaker
Prof. Andrew Davies
Professor Of Haematological Oncology
University of Southampton
-
Ms. Bronagh McGoldrick
Clinical Specialist Physiotherapist - BMT & Haematology
Cardiff and Vale University Health Board
-
Ms. Katie Brice
CAR T-cell Therapy Specialist Nurse
Manchester University NHS Foundation Trust
-
Dr. Francesca Sillito
Cellular Therapy Fellow
Royal Marsden Hospital
-
